KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Encompass Health (EHC) Shares Outstanding (Diluted Average) (2016 - 2026)

Encompass Health (EHC) has disclosed Shares Outstanding (Diluted Average) for 18 consecutive years, with $100.6 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) fell 1.47% year-over-year to $100.6 million; the TTM value through Mar 2026 reached $100.6 million, down 1.47%, while the annual FY2025 figure was $102.2 million, 0.0% changed from the prior year.
  • Shares Outstanding (Diluted Average) hit $100.6 million in Q1 2026 for Encompass Health, down from $102.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $102.3 million in Q3 2025 and bottomed at $100.2 million in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $101.4 million, with a median of $101.4 million recorded in 2023.
  • Year-over-year, Shares Outstanding (Diluted Average) rose 1.29% in 2024 and then dropped 1.47% in 2026.
  • Encompass Health's Shares Outstanding (Diluted Average) stood at $100.4 million in 2022, then increased by 0.9% to $101.3 million in 2023, then rose by 0.89% to $102.2 million in 2024, then changed by 0.0% to $102.2 million in 2025, then dropped by 1.57% to $100.6 million in 2026.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $100.6 million, $102.2 million, and $102.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.